Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Predictors of the discharge dosage of an atypical antipsychotic agent among hospitalized, treatment-naive, first-episode psychosis patients in naturalistic, public-sector settings.

Compton MT, Kelley ME, Lloyd RB, McClam T, Ramsay CE, Haggard PJ, Augustin S.

J Clin Psychopharmacol. 2011 Feb;31(1):10-5. doi: 10.1097/JCP.0b013e3182042154.

PMID:
21192136
2.

[Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France].

Grolleau A, Cougnard A, Parrot M, Kalmi E, Desage A, Misdrahi D, Brun-Rousseau H, Verdoux H.

Encephale. 2007 May-Jun;33(3 Pt 1):326-31. French.

PMID:
17675930
3.

A naturalistic study of risperidone treatment outcome using prognosis-adjusted discharge rates in New York State inpatients.

Javitt DC, Cienfuegos A, Miniati M, Silipo G, Levine J, Allingham BH, Robinson J.

J Clin Psychiatry. 2002 Jul;63(7):585-90.

PMID:
12143914
4.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

5.

[Risperidone in the early treatment of first-episode psychosis: a two-year follow-up study].

Gutiérrez Fraile M, Segarra Echevarría R, González-Pinto Arrillaga A, Martínez Junquera G.

Actas Esp Psiquiatr. 2002 May-Jun;30(3):142-52. Spanish.

PMID:
12106515
6.

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

Kane JM, Leucht S, Carpenter D, Docherty JP; Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.

J Clin Psychiatry. 2003;64 Suppl 12:5-19.

7.

Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study.

Zarate CA Jr, Tohen M.

J Clin Psychiatry. 2000 Jan;61(1):33-8.

PMID:
10695644
8.

Choosing antipsychotic maintenance therapy--a naturalistic study.

Tavcar R, Dernovsek MZ, Zvan V.

Pharmacopsychiatry. 2000 Mar;33(2):66-71.

PMID:
10761822
9.

[Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].

Raignoux C, Dusouchet T, Bret P, Queuille E, Biscay ML, Caron J, Bret MC.

Encephale. 2007 Dec;33(6):973-81. doi: 10.1016/j.encep.2006.07.003. Epub 2007 Sep 4. French.

PMID:
18789790
10.

Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.

Janssen B, Gaebel W, Haerter M, Komaharadi F, Lindel B, Weinmann S.

Psychopharmacology (Berl). 2006 Aug;187(2):229-36. Epub 2006 May 19.

PMID:
16710714
11.
12.

Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.

Keck PE Jr, Wilson DR, Strakowski SM, McElroy SL, Kizer DL, Balistreri TM, Holtman HM, DePriest M.

J Clin Psychiatry. 1995 Oct;56(10):466-70.

PMID:
7559373
13.

Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis.

Lambert M, Conus P, Cotton S, Robinson J, McGorry PD, Schimmelmann BG.

J Clin Psychopharmacol. 2010 Oct;30(5):565-72. doi: 10.1097/JCP.0b013e3181f058a0.

PMID:
20814327
14.

Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol.

Coley KC, Carter CS, DaPos SV, Maxwell R, Wilson JW, Branch RA.

J Clin Psychiatry. 1999 Dec;60(12):850-6.

PMID:
10665632
15.

Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.

Wunderink L, Nienhuis FJ, Sytema S, Slooff CJ, Knegtering R, Wiersma D.

J Clin Psychiatry. 2007 May;68(5):654-61.

PMID:
17503973
16.

Patients with schizophrenia at risk for excessive antipsychotic dosing.

Walkup JT, McAlpine DD, Olfson M, Labay LE, Boyer C, Hansell S.

J Clin Psychiatry. 2000 May;61(5):344-8.

PMID:
10847308
17.

Medication adherence for children and adolescents with first-episode psychosis following hospitalization.

Gearing RE, Charach A.

Eur Child Adolesc Psychiatry. 2009 Oct;18(10):587-95. doi: 10.1007/s00787-009-0018-7. Epub 2009 Apr 21.

PMID:
19381709
18.

Pretreatment predictors of cognitive deficits in early psychosis.

González-Blanch C, Crespo-Facorro B, Alvarez-Jiménez M, Rodríguez-Sánchez JM, Pelayo-Terán JM, Pérez-Iglesias R, Vázquez-Barquero JL.

Psychol Med. 2008 May;38(5):737-46. Epub 2007 Oct 9.

PMID:
17922942
19.

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA.

Arch Gen Psychiatry. 1999 Mar;56(3):241-7.

PMID:
10078501
20.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596

Supplemental Content

Support Center